4//SEC Filing
Fraser Claire 4
Accession 0000950170-25-093273
CIK 0001609809other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:34 PM ET
Size
5.7 KB
Accession
0000950170-25-093273
Insider Transaction Report
Form 4
Fraser-Liggett Claire
Director
Transactions
- Award
Stock Option (right to buy)
2025-07-01+6,452→ 6,452 totalExercise: $10.71Exp: 2035-07-01→ Common Stock (6,452 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2025, January 1, 2026, April 1, 2026, and July 1, 2026, provided that if the issuer's 2026 annual meeting of stockholders occurs before July 1, 2026, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001382031
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:34 PM ET
- Size
- 5.7 KB